M&A Deal Summary

Clinical Microbiomics Acquires DNASense

On March 1, 2024, Clinical Microbiomics acquired life science company DNASense

Acquisition Highlights
  • This is Clinical Microbiomics’ 2nd transaction in the Life Science sector.
  • This is Clinical Microbiomics’ 2nd transaction in Denmark.

M&A Deal Summary
Date 2024-03-01
Target DNASense
Sector Life Science
Buyer(s) Clinical Microbiomics
Deal Type Add-on Acquisition

Target

DNASense

Aalborg, Denmark
website
DNASense is a microbiome CRO specialized in long-read DNA and RNA sequencing technologies, and the associated cutting-edge bioinformatics. DNASense was founded in 2014 and is based in Aalborg, Denmark.

Search 193,092 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Clinical Microbiomics

Copenhagen, Denmark

website

Category Company
Founded 2015
Sector Life Science
DESCRIPTION

Clinical Microbiomics is a contract research organization specializing in microbiome and metabolome analysis. Clinical Microbiomics was founded in 2015 and is based in Copenhagen, Denmark.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
Country (Denmark) 2 of 2
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-17 MS-Omics

Vedbæk, Denmark

MS-Omics is a service provider of metabolomics and data analysis that supports your analysis needs, from small to large studies. MS-Omics was founded in 2014 and is based in Vedbæk, Denmark.

Buy -
Mergr

Product

Company

Legal